Response to the letter to the editor on “an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy”

Hollis Lin, Sonalee Agarwal, Marissa Betts, Kyle Fahrbach, Madhura Chitnis, Michael Polydefkis

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1529-1530
Number of pages2
JournalExpert opinion on pharmacotherapy
Issue number12
StatePublished - 2019


  • Transthyretin amyloid polyneuropathy
  • indirect treatment comparison

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this